Navigating the Regulatory Landscape in Nepal's Clinical Research

  • October 31, 2023

Navigating the Regulatory Landscape in Nepal’s Clinical Research: A Comprehensive Guide

Navigating the Regulatory Landscape in Nepal’s Clinical Research: A Comprehensive Guide

Tags :

    Related Posts

    Patient Advocacy in Clinical Trials

    • January 22, 2024

    The infamous Tuskegee Syphilis Study , spanning from 1932 to 1972 in Alabama, shockingly lacked essential patient safety measures, leading to its eventual termination. Victims of the study were not only left uninformed about syphilis, but they were also denied access to available treatment facilities.

    Read More

    Commonly Used Clinical Research Study Designs

    • January 15, 2024

    Clinical research utilizes diverse study designs to explore medical inquiries. From observational studies to experimental trials, each design offers unique insights. Researchers choose designs based on their specific questions, aiming for reliable and valid results. Understanding these study designs is crucial for advancing medical knowledge, improving treatments, and enhancing healthcare practices.

    Read More

    Investigational Medicinal Product (IMP) Handling in Clinical Trials: Insights from Nepal

    • January 22, 2024

    National Guideline On Clinical Trials With The Use Of Pharmaceutical Products , published by National Health Research Council (NHRC) defines Investigational Medicinal Product (IMP/IP) as any pharmaceutical form of an active ingredient or placebo undergoing testing in a clinical trial.

    Read More